(Q37301526)

19 August 2017

1 reference

title

Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management (English)

1 reference

19 August 2017

1 reference

1 reference

Caryn Dutton

1

1 reference

19 August 2017

Nancy Foldvary-Schaefer

series ordinal

2

1 reference

19 August 2017

publication date

1 January 2008

1 reference

International Review of Neurobiology

19 August 2017

published in

1 reference

19 August 2017

volume

83

1 reference

19 August 2017

page(s)

113-134

1 reference

Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Oral Contraceptives Induce Lamotrigine Metabolism: Evidence from a Double-blind, Placebo-controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Interactions between antiepileptic drugs and hormonal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Gender difference in management of epilepsy-what women are hearing.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Time to pardon the IUD?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Reproductive history, sexual behavior and use of contraception in women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Interaction of anticonvulsants and oral contraceptives in epileptic adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Epilepsy and Oral Contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Catamenial epilepsy: pathophysiology, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Increased Apparent Oral Clearance of Valproic Acid during Intake of Combined Contraceptive Steroids in Women with Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Three patterns of catamenial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Unplanned pregnancy in an epileptic

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Possible interaction between oxcarbazepine and an oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Treatment of seizures with medroxyprogesterone acetate: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Health issues for women with epilepsy: a descriptive survey to assess knowledge and awareness among healthcare providers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Contraception for women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

The care of pregnant women with epilepsy--a survey of obstetricians in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Lamotrigine plasma levels reduced by oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Oral contraceptives reduce lamotrigine plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Analysis of prenatal and gestational care given to women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900006-8

7 January 2021

10.1016/S0074-7742(08)00006-8

Identifiers

DOI

1 reference

19 August 2017

1 reference